Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Neighbourly Pharmacy Inc T.NBLY

Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy’s RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or... see more

TSX:NBLY - Post Discussion

Neighbourly Pharmacy Inc > As Long as the "Formal Valuation" is a minimum $18.50...
View:
Post by StewartCatso on Dec 18, 2023 10:42am

As Long as the "Formal Valuation" is a minimum $18.50...

(iii) receipt from TD Securities Inc. ("TD"), financial advisor and independent valuator to the committee of independent directors (the "Transaction Committee") formed by the Board of Directors of the Company (the "Board"), of an updated formal valuation of the Common Shares initially orally delivered by TD to the Transaction Committee on October 2, 2023 (the "Formal Valuation"); and (iv) receipt from TD of an updated fairness opinion initially orally delivered by TD to the Transaction Committee on October 2, 2023 (the "Fairness Opinion"), containing a fairness conclusion consistent with the Fairness Opinion.

There is no reason not to take this offer to a Minority Shareholders vote to accept or reject the offer.
Comment by Kanatainvestor on Dec 18, 2023 10:49am
They may very well take it to a vote since they own enough shares to do so, but I don't see the board endorsing the offer as it stands to day. 
Comment by CarsT1 on Dec 18, 2023 10:58am
considering where shares were trading before the original offer, despite the indigestion on todays news, I see shareholders accepting the new offer. in my world, 18.50 is better than 12.50 GLTA
Comment by StewartCatso on Dec 18, 2023 11:02am
Assuming a "Formal Evaluation" of $18.50, then the company cannot disallow the Minority Shareholders to vote on it. The lawyers for all parties will have a field day with this puppy... Oppression Remedy The oppression remedy is available under the CBCA and the OBCA and it is one of the most powerful tools that minority shareholders have to protect their rights. ...more  
Comment by Kanatainvestor on Dec 18, 2023 11:35am
PCP doesn't need the board or TD’s fairness opinion to call a special shareholders meeting and put the deal to a vote. (Any shareholder who owns 5% or more of the share can put pretty much anything to a vote). The way, the stock is trading tells me that the market doesn’t believe that PCP can get the majority of the minority of the vote. As such, PCP will either have to up the offer or abandon ...more  
Comment by gunner1324 on Dec 18, 2023 12:05pm
And where does this end up if they back out , back in the 12`$
Comment by Kanatainvestor on Dec 18, 2023 1:00pm
I don't see this going back to $12s with interest rates where they are (the yield on Canadian 10 sovereigns is down to 3.17% from 4.25% when the first $20.5 offer was made). If you look at PLC, DNTL and the likes they have rallied substantially the last few weeks as investors started pricing a meaningful reduction in interest rates in 2024. If you combine that with the pharmacists shortage ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities